MLchartDataset catalogue

tumor peptide-loaded myeloid dendritic cells

Term · Oncology and biomedicine · MLC-T-ONC-017368

A cell-based cancer vaccine composed of myeloid dendritic cells (myDCs) pulsed with tumor peptides with potential immunostimulatory and antineoplastic activities. Upon administration, the tumor peptide-loaded myDCs stimulate a specific cytotoxic T-lymphocyte (CTL) response against the tumor cells, resulting in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-017368
FieldOncology and biomedicine
Synonymstumor peptide-loaded myDC vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017368",
  "term": "tumor peptide-loaded myeloid dendritic cells",
  "field": "Oncology and biomedicine",
  "definition": "A cell-based cancer vaccine composed of myeloid dendritic cells (myDCs) pulsed with tumor peptides with potential immunostimulatory and antineoplastic activities. Upon administration, the tumor peptide-loaded myDCs stimulate a specific cytotoxic T-lymphocyte (CTL) response against the tumor cells, resulting in tumor cell lysis.",
  "synonyms": [
    "tumor peptide-loaded myDC vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/tumor-peptide-loaded-myeloid-dendritic-cells/"
}

Record 16,832 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.